ALAMEDA, Calif.–(BUSINESS WIRE)–InSite Vision and Sun Pharma Enter Into Merger Agreement
Zeiss builds on range of ophthalmic products
BARCELONA — Carl Zeiss Meditec introduced additions and enhancements to a range of ophthalmic products at the European Society of Cataract and Refractive Surgeons meeting.In particular, Visuconnect 500 software adds networking capability to Zeiss’s line of basic diagnostics devices, Opmi Lumera 300 is a new surgical microscope, and the SL 220 slit lamp features a new user interface and tower design, Ralf Kuschnereit, PhD, head of the Ophthalmic Systems Division, reported at a company press briefing.
FDA gives orphan drug designation to MANF for retinal artery occlusion
The FDA granted orphan drug designation to Amarantus BioScience Holdings for its investigational retinal artery occlusion treatment drug MANF, according to a press release.Mesencephalic-astrocyte-derived neurotrophic factor (MANF) is a natural protein …
Morning Break: Dr. Oz Chastened, Sanitizer High, Ebola Is Back
(MedPage Today) — Health news and commentary from around the Web, gathered by the MedPage Today staff
Penn Vet team identifies a form of congenital night blindness in dogs
People with congenital stationary night blindness, or CSNB, have normal vision during the day but find it difficult or impossible to distinguish objects in low light.
VIDEO: Management of phakic IOL explantation
BARCELONA — At the European Society of Cataract and Refractive Surgeons meeting, Antonio Marinho, MD, speaks the causes and management of phakic IOL explantation, which occurs in a high number of cases in the long term. He also expresses his opinion on the future role of this technology.